Cellvie: Funding, Investors & Team (Oct 2026)
Using the medicinal potential of mitochondria, the cell's powerhouses, Cellvie creates cell-derived medications. At the root of the origin of complex life are mitochondria. The future organelle, which was probably a bacterium at the time, joined with a basic organism to form a symbiotic relationship: The organism supplied the mitochondria with an environment to grow as they started to give the energy for complex cellular activities to evolve. Currently, all human cells, with the exception of red blood cells, include mitochondria. Due to their production of the majority of the energy (ATP) and participation in numerous cellular and metabolic processes, they play a crucial role in determining the fate of individual cells.
Cellvie has raised $10.5M across 2 funding rounds on record, the most recent a Seed of $5.0M announced in Sep 2025.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Cellvie Company Profile and Key Stats
Latest funding round on record: Sep 2025.
Cellvie Funding Rounds
Cellvie raised $5.5M in a Seed announced in Feb 2023.
2.6 years later, a Seed of $5.0M was announced in Sep 2025.
Cellvie Founders and Leadership Team
Contact details for the Cellvie team: 1 of 2 have an email address on file.
Start 14-day free trial →Cellvie Funding Compared to Other Biotechnology Startups
Cellvie's latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Cellvie in Biotechnology and Houston
Companies Similar to Cellvie
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Cellvie Funding FAQs
What does Cellvie do?
Using the medicinal potential of mitochondria, the cell's powerhouses, Cellvie creates cell-derived medications. At the root of the origin of complex life are mitochondria. The future organelle, which was probably a bacterium at the time, joined with a basic organism to form a symbiotic relationship: The organism supplied the mitochondria with an environment to grow as they started to give the energy for complex cellular activities to evolve. Currently, all human cells, with the exception of red blood cells, include mitochondria. Due to their production of the majority of the energy (ATP) and participation in numerous cellular and metabolic processes, they play a crucial role in determining the fate of individual cells.
How much funding has Cellvie raised?
Cellvie has raised $10.5M across 2 rounds on record. The most recent is a Seed of $5.0M announced in Sep 2025.
When did Cellvie last raise funding?
Cellvie's most recent funding round on record is a Seed of $5.0M, announced in Sep 2025.
Who founded Cellvie?
FundedIQ lists James Mccully (Founder) at Cellvie.
Where is Cellvie headquartered?
Cellvie is based in Houston, Texas, United States.
How many employees does Cellvie have?
Cellvie is in the 1-10 employee band.
How does Cellvie's funding compare to other Biotechnology startups?
Cellvie's latest round of $5.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Cellvie Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cellvie is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.